{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:48:38Z","timestamp":1753519718668,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Celiac disease (CD) is a known risk factor for osteoporosis and fractures. The prevalence of CD in patients with a recent fracture is unknown. We therefore systematically screened patients at a fracture liaison service (FLS) to study the prevalence of CD. Patients with a recent fracture aged\u2009\u2265\u200950\u00a0years were invited to VieCuri Medical Center\u2019s FLS. In FLS attendees, bone mineral density (BMD) and laboratory evaluation for metabolic bone disorders and serological screening for CD was systematically evaluated. If serologic testing for CD was positive, duodenal biopsies were performed to confirm the diagnosis CD. Data were collected in 1042 consecutive FLS attendees. Median age was 66\u00a0years (Interquartile range (IQR) 15), 27.6% had a major and 6.9% a hip fracture, 26.4% had osteoporosis and 50.8% osteopenia. Prevalent vertebral fractures were found in 29.1%. CD was already diagnosed in two patients (0.19%), one still had a positive serology. Three other patients (0.29%) had a positive serology for CD (one with gastro-intestinal complaints). In two of them, CD was confirmed by duodenal histology (0.19%) and one refused further evaluation. The prevalence of biopsy-proven CD was therefore 0.38% (4\/1042) of which 0.19% (2\/1042) was newly diagnosed. The prevalence of CD in patients with a recent fracture at the FLS was 0.38% and within the range of reported prevalences in the Western-European population (0.33\u20131.5%). Newly diagnosed CD was only found in 0.19%. Therefore, standard screening for CD in FLS patients is not recommended.<\/jats:p>","DOI":"10.1007\/s00223-020-00725-z","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T17:26:17Z","timestamp":1595957177000},"page":"327-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Prevalence of Celiac Disease in a Fracture Liaison Service Population"],"prefix":"10.1007","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5776-4971","authenticated-orcid":false,"given":"Irma J. A.","family":"de Bruin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-4397","authenticated-orcid":false,"given":"Lisanne","family":"Vranken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7662-3990","authenticated-orcid":false,"given":"Caroline E.","family":"Wyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-6943","authenticated-orcid":false,"given":"Robert Y.","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0464-1863","authenticated-orcid":false,"given":"Thera A. M.","family":"Trienekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-4464","authenticated-orcid":false,"given":"Sjoerd","family":"Kaarsemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-5840","authenticated-orcid":false,"given":"Heinrich M. J.","family":"Janzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-1675","authenticated-orcid":false,"given":"Frank L.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-0128","authenticated-orcid":false,"given":"Siep","family":"Wouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-9146","authenticated-orcid":false,"given":"Piet P. M. M.","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-2232","authenticated-orcid":false,"given":"Joop P. W.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,28]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","volume":"62","author":"JF Ludvigsson","year":"2013","unstructured":"Ludvigsson JF, Leffler DA, Bai JC et al (2013) The Oslo definitions for coeliac disease and related terms. Gut 62:43\u201352","journal-title":"Gut"},{"key":"725_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12876-014-0194-x","volume":"14","author":"U Volta","year":"2014","unstructured":"Volta U, Caio G, Stanghellini V, De Giorgio R (2014) The changing clinical profile of celiac disease: a 15-year experience (1998\u20132012) in an Italian referral center. BMC Gastroenterol 14:194. https:\/\/doi.org\/10.1186\/s12876-014-0194-x","journal-title":"BMC Gastroenterol"},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11914-016-0304-5","volume":"14","author":"MB Zanchetta","year":"2016","unstructured":"Zanchetta MB, Longobardi V, Bai JC (2016) Bone and celiac disease. Curr Osteoporos Rep 14:43\u201348. https:\/\/doi.org\/10.1007\/s11914-016-0304-5","journal-title":"Curr Osteoporos Rep"},{"key":"725_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.dld.2007.09.006","volume":"40","author":"M Olmos","year":"2008","unstructured":"Olmos M, Antelo M, Vazquez H et al (2008) Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 40:46\u201353. https:\/\/doi.org\/10.1016\/j.dld.2007.09.006","journal-title":"Dig Liver Dis"},{"key":"725_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00198-014-2683-8","volume":"25","author":"AM Hjelle","year":"2014","unstructured":"Hjelle AM, Apalset E, Mielnik P et al (2014) Celiac disease and risk of fracture in adults\u2013a review. Osteoporos Int 25:1667\u20131676. https:\/\/doi.org\/10.1007\/s00198-014-2683-8","journal-title":"Osteoporos Int"},{"key":"725_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/jc.2014-1858","volume":"100","author":"K Heikkil\u00e4","year":"2015","unstructured":"Heikkil\u00e4 K, Pearce J, M\u00e4ki M, Kaukinen K (2015) Celiac disease and bone fractures: a systematic review and meta-analysis. J Clin Endocrinol Metab 100:25\u201334. https:\/\/doi.org\/10.1210\/jc.2014-1858","journal-title":"J Clin Endocrinol Metab"},{"key":"725_CR7","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00198-008-0624-0","volume":"19","author":"M-L Bianchi","year":"2008","unstructured":"Bianchi M-L, Bardella MT (2008) Bone in celiac disease. Osteoporos Int 19:1705\u20131716. https:\/\/doi.org\/10.1007\/s00198-008-0624-0","journal-title":"Osteoporos Int"},{"key":"725_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jocd.2013.08.012","volume":"16","author":"Y Xing","year":"2013","unstructured":"Xing Y, Morgan SL (2013) Celiac disease and metabolic bone disease. J Clin Densitom 16:439\u2013444. https:\/\/doi.org\/10.1016\/j.jocd.2013.08.012","journal-title":"J Clin Densitom"},{"key":"725_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1572-0241.1998.00413.x","volume":"93","author":"MC Fornari","year":"1998","unstructured":"Fornari MC, Pedreira S, Niveloni S et al (1998) Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia? Am J Gastroenterol 93:413\u2013418. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.00413.x","journal-title":"Am J Gastroenterol"},{"key":"725_CR10","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3390\/nu7053347","volume":"7","author":"P Grace-Farfaglia","year":"2015","unstructured":"Grace-Farfaglia P (2015) Bones of contention: bone mineral density recovery in celiac disease\u2013a systematic review. Nutrients 7:3347\u20133369. https:\/\/doi.org\/10.3390\/nu7053347","journal-title":"Nutrients"},{"key":"725_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2036.2000.00671.x","volume":"14","author":"C Sategna-Guidetti","year":"2000","unstructured":"Sategna-Guidetti C, Grosso SB, Grosso S et al (2000) The effects of 1-year gluten withdrawal on bone mass, bone metabolism and nutritional status in newly-diagnosed adult coeliac disease patients. Aliment Pharmacol Ther 14:35\u201343","journal-title":"Aliment Pharmacol Ther"},{"key":"725_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s8756-3282(99)00171-4","volume":"25","author":"T Kemppainen","year":"1999","unstructured":"Kemppainen T, Kroger H, Janatuinen E et al (1999) Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone 25:355\u2013360. https:\/\/doi.org\/10.1016\/s8756-3282(99)00171-4","journal-title":"Bone"},{"key":"725_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2036.2006.03203.x","volume":"25","author":"JF Ludvigsson","year":"2007","unstructured":"Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM (2007) Coeliac disease and the risk of fractures\u2014a general population-based cohort study. Aliment Pharmacol Ther 25:273\u2013285. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03203.x","journal-title":"Aliment Pharmacol Ther"},{"key":"725_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA et al (2018) Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:823\u2013836.e2. https:\/\/doi.org\/10.1016\/j.cgh.2017.06.037","journal-title":"Clin Gastroenterol Hepatol"},{"key":"725_CR15","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1053\/j.gastro.2005.02.014","volume":"128","author":"C Dub\u00e9","year":"2005","unstructured":"Dub\u00e9 C, Rostom A, Sy R et al (2005) The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128:S57\u2013S67. https:\/\/doi.org\/10.1053\/j.gastro.2005.02.014","journal-title":"Gastroenterology"},{"key":"725_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/00365529950173681","volume":"34","author":"K Rostami","year":"1999","unstructured":"Rostami K, Mulder CJ, Werre JM et al (1999) High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol 34:276\u2013279. https:\/\/doi.org\/10.1080\/00365529950173681","journal-title":"Scand J Gastroenterol"},{"key":"725_CR17","first-page":"1055","volume":"59","author":"LP Rios","year":"2013","unstructured":"Rios LP, Khan A, Sultan M et al (2013) Approach to diagnosing celiac disease in patients with low bone mineral density or fragility fractures: multidisciplinary task force report. Can Fam Physician 59:1055\u20131061","journal-title":"Can Fam Physician"},{"key":"725_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/apt.14911","volume":"48","author":"M Laszkowska","year":"2018","unstructured":"Laszkowska M, Mahadev S, Sundstr\u00f6m J et al (2018) Systematic review with meta-analysis: the prevalence of coeliac disease in patients with osteoporosis. Aliment Pharmacol Ther 48:590\u2013597. https:\/\/doi.org\/10.1111\/apt.14911","journal-title":"Aliment Pharmacol Ther"},{"key":"725_CR19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00198-003-1507-z","volume":"14","author":"AR McLellan","year":"2003","unstructured":"McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028\u20131034. https:\/\/doi.org\/10.1007\/s00198-003-1507-z","journal-title":"Osteoporos Int"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K \u00c5kesson","year":"2013","unstructured":"\u00c5kesson K, Marsh D et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152. https:\/\/doi.org\/10.1007\/s00198-013-2348-z","journal-title":"Osteoporos Int"},{"key":"725_CR21","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2010-2135","volume":"96","author":"SPG Bours","year":"2011","unstructured":"Bours SPG, van Geel TACM, Geusens PPMM et al (2011) Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab 96:1360\u20131367. https:\/\/doi.org\/10.1210\/jc.2010-2135","journal-title":"J Clin Endocrinol Metab"},{"key":"725_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/BOR.0000000000000074","volume":"26","author":"SPG Bours","year":"2014","unstructured":"Bours SPG, van den Bergh JPW, van Geel TACM, Geusens PPMM (2014) Secondary osteoporosis and metabolic bone disease in patients 50 years and older with osteoporosis or with a recent clinical fracture: a clinical perspective. Curr Opin Rheumatol 26:430\u2013439. https:\/\/doi.org\/10.1097\/BOR.0000000000000074","journal-title":"Curr Opin Rheumatol"},{"key":"725_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.berh.2019.03.016","volume":"33","author":"P Geusens","year":"2019","unstructured":"Geusens P, Bours SPG, Wyers CE, van den Bergh JP (2019) Fracture liaison programs. Best Pract Res Clin Rheumatol 33:278\u2013289. https:\/\/doi.org\/10.1016\/j.berh.2019.03.016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"725_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11657-016-0258-3","volume":"11","author":"F Malgo","year":"2016","unstructured":"Malgo F, Appelman-Dijkstra NM, Termaat MF et al (2016) High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD. Arch Osteoporos 11:12. https:\/\/doi.org\/10.1007\/s11657-016-0258-3","journal-title":"Arch Osteoporos"},{"key":"725_CR25","unstructured":"Reumatologie NVV (2011) CBO richtlijn osteoporose en fractuurpreventie"},{"key":"725_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jama.297.4.387","volume":"297","author":"JR Center","year":"2007","unstructured":"Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387\u2013394. https:\/\/doi.org\/10.1001\/jama.297.4.387","journal-title":"JAMA"},{"key":"725_CR27","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s00198-013-2413-7","volume":"24","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, Adachi JD, Cooper C et al (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int 24:2763\u20132764","journal-title":"Osteoporos Int"},{"key":"725_CR28","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148. https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J Bone Miner Res"},{"key":"725_CR29","unstructured":"van Maag-Darm-Leverartsen NV (2008) Richtlijn Coeliakie en Dermatitis Herpetiformis"},{"key":"725_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ajg.2013.79","volume":"108","author":"A Rubio-Tapia","year":"2013","unstructured":"Rubio-Tapia A, Hill ID, Kelly CP et al (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108:656\u2013676. https:\/\/doi.org\/10.1038\/ajg.2013.79","journal-title":"Am J Gastroenterol"},{"key":"725_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jgh.13176","volume":"31","author":"K Pallav","year":"2016","unstructured":"Pallav K, Xu H, Leffler DA et al (2016) Immunoglobulin A deficiency in celiac disease in the United States. J Gastroenterol Hepatol 31:133\u2013137. https:\/\/doi.org\/10.1111\/jgh.13176","journal-title":"J Gastroenterol Hepatol"},{"key":"725_CR32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","volume":"102","author":"MN Marsh","year":"1992","unstructured":"Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u201cceliac sprue\u201d). Gastroenterology 102:330\u2013354","journal-title":"Gastroenterology"},{"key":"725_CR33","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","volume":"11","author":"G Oberhuber","year":"1999","unstructured":"Oberhuber G, Granditsch G, Vogelsang H (1999) The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11:1185\u20131194. https:\/\/doi.org\/10.1097\/00042737-199910000-00019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"725_CR34","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","volume":"63","author":"JF Ludvigsson","year":"2014","unstructured":"Ludvigsson JF, Bai JC, Biagi F et al (2014) Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 63:1210\u20131228. https:\/\/doi.org\/10.1136\/gutjnl-2013-306578","journal-title":"Gut"},{"key":"725_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MCG.0b013e31827a6f83","volume":"47","author":"JC Bai","year":"2013","unstructured":"Bai JC, Fried M, Corazza GR et al (2013) World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 47:121\u2013126. https:\/\/doi.org\/10.1097\/MCG.0b013e31827a6f83","journal-title":"J Clin Gastroenterol"},{"key":"725_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jbspin.2008.06.016","volume":"76","author":"I Legroux-G\u00e9rot","year":"2009","unstructured":"Legroux-G\u00e9rot I, Leloire O, Blanckaert F et al (2009) Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 76:162\u2013165. https:\/\/doi.org\/10.1016\/j.jbspin.2008.06.016","journal-title":"Joint Bone Spine"},{"key":"725_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2796.2001.00895.x","volume":"250","author":"R Nuti","year":"2001","unstructured":"Nuti R, Martini G, Valenti R et al (2001) Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med 250:361\u2013366","journal-title":"J Intern Med"},{"key":"725_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00223-001-1027-9","volume":"71","author":"D Gonz\u00e1lez","year":"2002","unstructured":"Gonz\u00e1lez D, Sugai E, Gomez JC et al (2002) Is it necessary to screen for celiac disease in postmenopausal osteoporotic women? Calcif Tissue Int 71:141\u2013144. https:\/\/doi.org\/10.1007\/s00223-001-1027-9","journal-title":"Calcif Tissue Int"},{"key":"725_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1258\/000456306776021599","volume":"43","author":"PG Hill","year":"2006","unstructured":"Hill PG, McMillan SA (2006) Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease. Ann Clin Biochem 43:105\u2013117. https:\/\/doi.org\/10.1258\/000456306776021599","journal-title":"Ann Clin Biochem"},{"key":"725_CR40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/00365521.2018.1509122","volume":"53","author":"AM Hjelle","year":"2018","unstructured":"Hjelle AM, Apalset E, Mielnik P et al (2018) Positive IgA against transglutaminase 2 in patients with distal radius and ankle fractures compared to community-based controls. Scand J Gastroenterol 53:1212\u20131216. https:\/\/doi.org\/10.1080\/00365521.2018.1509122","journal-title":"Scand J Gastroenterol"},{"key":"725_CR41","doi-asserted-by":"publisher","first-page":"198025","DOI":"10.1155\/2012\/198025","volume":"2012","author":"T Larussa","year":"2012","unstructured":"Larussa T, Suraci E, Nazionale I et al (2012) Bone mineralization in celiac disease. Gastroenterol Res Pract 2012:198025\u2013198029. https:\/\/doi.org\/10.1155\/2012\/198025","journal-title":"Gastroenterol Res Pract"},{"key":"725_CR42","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/j.1532-5415.2012.03997.x","volume":"60","author":"S Casella","year":"2012","unstructured":"Casella S, Zanini B, Lanzarotto F et al (2012) Celiac disease in elderly adults: clinical, serological, and histological characteristics and the effect of a gluten-free diet. J Am Geriatr Soc 60:1064\u20131069. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.03997.x","journal-title":"J Am Geriatr Soc"},{"key":"725_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4158\/EP12059.RA","volume":"19","author":"SMD Hudec","year":"2013","unstructured":"Hudec SMD, Camacho PM (2013) Secondary causes of osteoporosis. Endocr Pract 19:120\u2013128. https:\/\/doi.org\/10.4158\/EP12059.RA","journal-title":"Endocr Pract"},{"key":"725_CR44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3390\/nu11061276","volume":"11","author":"ID Croall","year":"2019","unstructured":"Croall ID, Trott N, Rej A et al (2019) A population survey of dietary attitudes towards gluten. Nutrients 11:1276. https:\/\/doi.org\/10.3390\/nu11061276","journal-title":"Nutrients"},{"key":"725_CR45","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1001\/jamainternmed.2016.5254","volume":"176","author":"H-S Kim","year":"2016","unstructured":"Kim H-S, Patel KG, Orosz E et al (2016) Time trends in the prevalence of celiac disease and gluten-free diet in the US population: results from the national health and nutrition examination surveys 2009\u20132014. JAMA Intern Med 176:1716\u20131717. https:\/\/doi.org\/10.1001\/jamainternmed.2016.5254","journal-title":"JAMA Intern Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00725-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-020-00725-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00725-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T23:22:24Z","timestamp":1627428144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-020-00725-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,28]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00725-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"type":"print","value":"0171-967X"},{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2020,7,28]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Janzing, Dr. Kaarsemaker, Dr. Trienekens, Dr. Vranken, Dr. van der Velde, Dr. Wyers, Dr. Wolters, and Dr. Wouda have nothing to disclose. Dr. de Bruin reports personal fees from Pfizer, personal fees from Novartis, personal fees from Sanofi, outside the submitted work; Dr. van den Bergh reports grants from Amgen, grants from Eli Lilly, grants from UCB, outside the submitted work; Dr. Geusens reports grants and personal fees from Amgen, grants from Pfizer, grants from MSD, grants from UCB, grants from Abbott, grants and personal fees from Lilly, grants from BMS, grants from Novartis, grants from Roche, grants from Will Pharma, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was waived by the medical research ethics committee of the Academic Hospital Maastricht\/University Maastricht (METC 2020-1508) in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. The Dutch Medical Research Involving Human Subjects Act does not apply to our study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}